Stilwell McDavid 4
4 · Coherus BioSciences, Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
Stilwell McDavid
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-06-09$13.42/sh+3,700$49,668→ 35,118 total
Footnotes (3)
- [F1]The transaction was executed in multiple trades in prices ranging from $13.415 to $13.4294, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F2]Includes 30,000 restricted stock units.
- [F3]Includes 1,418 shares acquired on May 14, 2021, pursuant to Issuer's employee stock purchase plan.